P024 Targeted point-of-care testing compared to syndromic management of urogenital infections in rwandan women. (14th July 2019)

• Record Type: Journal Article
• Authors: Wijgert, Janneke Van De; Verwijs, Marijn; Agaba, Stephen; Sumanyi, Jean Claude; Umulisa, Marie Michelle; Mwambarangwe, Lambert; Musengamana, Viateur; Uwineza, Mireille; Cuylaerts, Vicky; Crucitti, Tania; Jespers, Vicky
• Is Part Of: Sexually transmitted infections. Volume 95(2019)Supplement 1
• Page Start: A91
• Page End: A91
• Publication Date: 2019-07-14
• Subjects: diagnosis; Sexually transmitted diseases -- Periodicals; HIV infections -- Periodicals; 616.951005
• DOI: 10.1136/sextrans-2019-sti.233
• Languages: English
• ISSNs: 1368-4973

Abstract

Abstract : Background: Sexually transmitted and urogenital infections are typically managed by World Health Organisation (WHO)-recommended syndromic algorithms in resource-poor countries. Vaginal discharge (VDS) and lower abdominal pain (LAP) algorithms in women perform poorly. The main aim of the WISH study was to compare the performances of VDS/LAP algorithms incorporating point-of-care tests (POCTs), and of WHO syndromic algorithms, with gold standard test results. Methods: At-risk Rwandan women (N=705) underwent POCTs for bacterial vaginosis (BV; vaginal pH≥5·0) and Trichomonas vaginalis (TV; OSOM) regardless of symptom-reporting. Women with a positive risk score were POC-tested for Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG; GeneXpert). Vulvovaginal candidiasis (VVC) was treated presumptively. Nucleic acid amplification tests (NAATs) were done for CT/NG, TV, BV, and VVC on everyone and were used as gold standards. Results: NAAT-based prevalences were: 60/705 (8·5%) CT, 50/705 (7·1%) NG, 111/690 (16·1%) TV, 125/690 (18·1%) BV, and 59/690 (8·6%) VVC. Infection-specific sensitivities of the WHO VDS/LAP algorithms ranged from 58·3–74·6%, and specificities from 44·7–50·6%. WISH POCT-based algorithms had good sensitivity (68·5–76·0%) and specificity (97·4–100%) for CT, NG, and TV but low specificity for BV (41·2%; sensitivity 95·2%), and modest sensitivity (64·4%) and specificity (69·4%) for VVC. Sensitivity (73·6%) and specificity (100%) for BV improves by screening all women for vaginal pH, and confirmatory testing of those with pH≥5·5 (n=275). Speculum/bimanual examinations by a physician had limited added value (except in the case of LAP), and partner notification was suboptimal. Staff and participants considered POC testing feasible and acceptable. Conclusion: POC testing for urogenital infections in women improves performance and is feasible in resource-poor settings. The WHO VDS/LAP algorithms should therefore recommend POC testing whenever feasible. However, programmes would benefit from more affordable combined CT/NG POCTs, and POCTs combining BV, TV, and VVC diagnoses. Additional studies in other populations, including low prevalence populations, are warranted. Disclosure: No significant relationships.